IRIS - Res&Arch Institutional Research Information System - Research & Archive

D'AMORE, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.048
EU - Europa 774
AS - Asia 308
Totale 2.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.046
IE - Irlanda 209
SG - Singapore 157
IT - Italia 142
SE - Svezia 119
UA - Ucraina 105
CN - Cina 58
FI - Finlandia 58
HK - Hong Kong 50
RU - Federazione Russa 42
FR - Francia 29
DE - Germania 27
VN - Vietnam 23
GB - Regno Unito 16
TR - Turchia 11
CH - Svizzera 9
PL - Polonia 8
CZ - Repubblica Ceca 3
LB - Libano 3
NL - Olanda 3
AT - Austria 2
BE - Belgio 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
IN - India 1
JP - Giappone 1
MX - Messico 1
UZ - Uzbekistan 1
Totale 2.130
Salva come PNG Salva come JPEG
Città #
Chandler 263
Dublin 209
Singapore 129
San Mateo 104
Altamura 69
Boardman 63
Santa Clara 56
Hong Kong 50
Medford 49
Perugia 49
Lawrence 48
Princeton 48
Jacksonville 42
Wilmington 35
Andover 34
Ann Arbor 25
Dong Ket 23
Beijing 22
Des Moines 12
Helsinki 12
Saint Petersburg 12
Izmir 11
Dearborn 9
San Paolo di Civitate 9
Ashburn 5
Falls Church 5
Norwalk 5
Houston 3
London 3
Olomouc 3
Brussels 2
Den Haag 2
Los Angeles 2
New York 2
Seoul 2
Shanghai 2
Woodbridge 2
Al Ain City 1
Amsterdam 1
Bologna 1
Chennai 1
Dallas 1
Deruta 1
Frankfurt Am Main 1
Guangzhou 1
Hanover 1
Hefei 1
Kunming 1
Lausanne 1
Moscow 1
Munich 1
Nanchang 1
Nanjing 1
Napoli 1
Phoenix 1
Redmond 1
Redwood City 1
Rovato 1
Shenyang 1
Shenzhen 1
Tappahannock 1
Tokyo 1
Tolentino 1
Toronto 1
Totale 1.448
Salva come PNG Salva come JPEG
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 88
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 85
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 73
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 69
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 68
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 64
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 64
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 63
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 60
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 58
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 58
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 57
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 57
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 56
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 56
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 53
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 53
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 52
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 48
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 47
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 46
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 45
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 44
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 43
Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists. 43
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 43
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 42
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 41
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 41
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 40
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 40
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 38
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 37
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 35
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 35
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 34
New tridecapeptides of the theonellapeptolide family from the Indonesian sponge Theonella swinhoei. 32
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 31
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 30
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 30
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 29
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 29
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 28
Oxygenated polyketides from Plakinastrella mamillaris as a new chemotype of PXR agonists. 26
Incisterols, highly degraded marine sterols, are a new chemotype of PXR agonists. 26
Isoswinholide B and swinholide K, potently cytotoxic dimeric macrolides from Theonella swinhoei. 24
Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulation. 24
Phallusiasterols A and B: two new sulfated sterols from the Mediterranean tunicate Phallusia fumigata and their effects as modulators of the PXR receptor. 20
Totale 2.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 13 27 2 23 12 2 0
2020/2021282 1 21 15 19 107 21 13 1 26 10 20 28
2021/2022366 5 63 0 20 12 2 2 138 1 14 45 64
2022/2023801 48 166 1 106 60 74 0 36 288 1 16 5
2023/2024209 19 35 16 1 1 0 44 3 8 4 52 26
2024/2025247 3 53 26 18 135 12 0 0 0 0 0 0
Totale 2.205